Launch of Xanitin Capsule, a treatment for peptic ulcers without side effects
In January 2000, KyungDong Pharm launched Xanitin Capsules, a peptic ulcer treatment containing nizatidine, for the first time in the domestic industry.
Zanitin Capsule is a product produced with nizatidine, developed and patented using KyungDong Pharm's pure technology, and significantly reduces gastric acid secretion by selectively blocking H2 receptors, making it an effective treatment for gastric acid-related digestive diseases, including peptic ulcers.
| Zanitin Capsules |
|
● Ingredients/Content Nizatidine 150mg in 1 capsule
●Efficacy/Effectiveness Gastroduodenal ulcer, prevention of recurrence of duodenal ulcer, reflux esophagitis, symptoms of gastroesophageal reflux disease Improvement of gastric mucosal lesions (erosions, redness, edema, bleeding) in acute gastritis and acute exacerbation of chronic gastritis.
●Usage/Dosage ▶ Stomach/duodenal ulcer Adults: As nizatidine, take 300 mg once a day at bedtime or 150 mg twice a day in the morning and evening. ▶ Prevent duodenal ulcer recurrence Adults: 150 mg once a day at bedtime ▶ Reflux esophagitis Adults: 150 mg orally twice a day, morning and evening, for up to 12 weeks. ▶ Gastroesophageal reflux disease (GERD) symptoms (heartburn, etc.) Adults: 150 mg orally twice a day, morning and evening, for up to 12 weeks. ▶ Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in acute gastritis and chronic gastritis Adults: 150 mg twice a day in the morning and before bedtime for 2 weeks.
●Packing unit 100 capsules, 300 capsules |